337 related articles for article (PubMed ID: 34570453)
21. Targeted therapy in pediatric low-grade glioma.
Kilday JP; Bartels UK; Bouffet E
Curr Neurol Neurosci Rep; 2014 Apr; 14(4):441. PubMed ID: 24604059
[TBL] [Abstract][Full Text] [Related]
22. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
23. Molecularly targeted therapies for malignant gliomas: advances and challenges.
Penas-Prado M; Gilbert MR
Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
[TBL] [Abstract][Full Text] [Related]
24. TGF-β as a therapeutic target in high grade gliomas - promises and challenges.
Joseph JV; Balasubramaniyan V; Walenkamp A; Kruyt FA
Biochem Pharmacol; 2013 Feb; 85(4):478-85. PubMed ID: 23159669
[TBL] [Abstract][Full Text] [Related]
25. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.
Batich KA; Sampson JH
Expert Opin Pharmacother; 2014 Oct; 15(14):2047-61. PubMed ID: 25139628
[TBL] [Abstract][Full Text] [Related]
26. Advances in the treatment of malignant gliomas.
Khasraw M; Lassman AB
Curr Oncol Rep; 2010 Jan; 12(1):26-33. PubMed ID: 20425605
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.
Ellingson BM; Wen PY; Cloughesy TF
Cancer J; 2021 Sep-Oct 01; 27(5):395-403. PubMed ID: 34570454
[TBL] [Abstract][Full Text] [Related]
28. Medical therapy of gliomas.
Ahluwalia MS; Chang SM
J Neurooncol; 2014 Sep; 119(3):503-12. PubMed ID: 24986089
[TBL] [Abstract][Full Text] [Related]
29. Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X; Zhang W; Mao XG; Cao WD; Zhen HN; Hu SJ
Curr Cancer Drug Targets; 2019; 19(2):101-108. PubMed ID: 29848277
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy for malignant gliomas.
Kornblith PL; Walker M
J Neurosurg; 1988 Jan; 68(1):1-17. PubMed ID: 3275753
[TBL] [Abstract][Full Text] [Related]
31. Improving outcomes for neurofibromatosis 1-associated brain tumors.
Brossier NM; Gutmann DH
Expert Rev Anticancer Ther; 2015 Apr; 15(4):415-23. PubMed ID: 25652347
[TBL] [Abstract][Full Text] [Related]
32. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers.
Gallia GL; Brem S; Brem H
J Natl Compr Canc Netw; 2005 Sep; 3(5):721-8. PubMed ID: 16194460
[TBL] [Abstract][Full Text] [Related]
33. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for low-grade gliomas.
Reddy AT; Packer RJ
Childs Nerv Syst; 1999 Oct; 15(10):506-13. PubMed ID: 10550582
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy for high-grade gliomas of childhood.
Pollack IF; Boyett JM; Finlay JL
Childs Nerv Syst; 1999 Oct; 15(10):529-44. PubMed ID: 10550584
[TBL] [Abstract][Full Text] [Related]
36. [Chemotherapy for malignant gliomas: an update].
Wakabayashi T; Natsume A; Fujii M
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1283-7. PubMed ID: 24105052
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy for malignant gliomas.
Kyritsis AP
Oncology (Williston Park); 1993 Sep; 7(9):93-100; discussion 103, 106. PubMed ID: 8217533
[TBL] [Abstract][Full Text] [Related]
38. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
39. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas.
Mudassar F; Shen H; O'Neill G; Hau E
J Exp Clin Cancer Res; 2020 Oct; 39(1):208. PubMed ID: 33028364
[TBL] [Abstract][Full Text] [Related]
40. Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.
Loya J; Zhang C; Cox E; Achrol AS; Kesari S
CNS Oncol; 2019 Nov; 8(3):CNS38. PubMed ID: 31747788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
